Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
P2Y purinoceptor 2 (P2Y2) is a G protein-coupled receptor activated by ATP and UTP. It plays a role in various physiological processes including chloride secretion, adipocyte differentiation, immune modulation, and cell cycle control. It is implicated in diseases like cystic fibrosis, obesity, and cancer, making it a potential therapeutic target. However, current antagonists face challenges related to selectivity and bioavailability.
Agonist or antagonist binding to the P2Y2 receptor, modulating downstream signaling pathways such as Ca²⁺/IP₃ and AKT/GSK3β/VEGF.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P2Y Purinoceptor 2 (P2Y2).